Darya-Varia Laboratoria Tbk PT operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Darya-Varia Laboratoria Tbk PT with three other
pharmaceutical manufacturers in Asia:
Shanxi C&Y Pharmaceutical Group Co Ltd
sales of 745.95 million Chinese Renmimbi [US$108.27 million]
of which 74%
was Pharmaceutical Manufacturing),
Ferozsons Laboratories Limited
(11.34 billion Pakistan Rupees [US$108.14 million]
Reyon Pharmaceutical Co Ltd
based in South Korea
(121.85 billion Korean Won [US$108.81 million]
During the year ended December of 2016, sales at
Darya-Varia Laboratoria Tbk PT were 1.45 trillion Indonesian Rupiahs (US$109.00 million).
increase of 11.1%
versus 2015, when the company's sales were 1.31 trillion Indonesian Rupiahs.
This was the fifth consecutive year of sales increases at Darya-Varia Laboratoria Tbk PT
(and since 2011, sales have increased a total of 49%).
Sales of Consumer Health saw an increase
that was more than double the company's growth rate: sales were up
50.2% in 2016, from
434.58 billion Indonesian Rupiahs to 652.63 billion Indonesian Rupiahs.
Not all segments of Darya-Varia Laboratoria Tbk PT experienced an increase in sales in 2016:
sales of Prescribed Medicines fell 17.3% to 479.51 billion Indonesian Rupiahs.